Drug class
Recombinant coagulation factor IX; antihaemorrhagic biologic
Mechanism of action
Recombinant human factor IX replaces deficient or absent factor IX in the intrinsic coagulation pathway. Activated factor IX, together with activated factor VIII, activates factor X and supports thrombin generation and fibrin clot formation.
General use cases
- Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency), under the authorised product indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
